---
layout: page
image:
  feature: DaubEnginePatent.jpg
---
   <head>
      <title>2758-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2700.html"><span>Chapter 2700</span></a></li>
      <li><span>Section 2758</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e277447">
                     <h1 class="page-title">2758
                        &nbsp;&nbsp;
                        Notice of Final Determination - Calculation of Patent Term
                        Extension [R-11.2013]
                     </h1>
                     <div id="d0e277451" class="USC">
                        <h4 class="USC"><i>35&nbsp;U.S.C.&nbsp;156 &nbsp;
                              
                              
                              
                              Extension of patent term.</i></h4>
                        <p class="excludedText"> ***** 
                           
                        </p>
                        <ul style="list-style-type: none;">
                           <li id="d0e277458" class="nobull">(c) The term of a patent
                              eligible for extension under subsection (a) shall be extended by the time equal
                              to the regulatory review period for the approved product which period occurs
                              after the date the patent is issued, except that—
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e277462" class="nobull">(1) each period of the
                                    regulatory review period shall be reduced by any period determined under
                                    subsection (d)(2)(B) during which the applicant for the patent extension
                                    did not act with due diligence during such period of the regulatory
                                    review period;
                                 </li>
                                 <li id="d0e277466" class="nobull">(2) after any reduction
                                    required by paragraph (1), the period of extension shall include only
                                    one-half of the time remaining in the periods described in paragraphs
                                    (1)(B)(i), (2)(B)(i), (3)(B)(i), (4)(B)(i), and (5)(B)(i) of subsection
                                    (g);
                                 </li>
                                 <li id="d0e277470" class="nobull">(3) if the period
                                    remaining in the term of a patent after the date of the approval of the
                                    approved product under the provision of law under which such regulatory
                                    review occurred when added to the regulatory review period as revised
                                    under paragraphs (1) and (2) exceeds fourteen years, the period of
                                    extension shall be reduced so that the total of both such periods does
                                    not exceed fourteen years, and
                                 </li>
                                 <li id="d0e277474" class="nobull">(4) in no event shall
                                    more than one patent be extended under subsection (e)(i) for the same
                                    regulatory review period for any product.
                                 </li>
                              </ul>
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                        <ul style="list-style-type: none;">
                           <li id="d0e277481" class="nobull">(6) A period determined under
                              any of the preceding paragraphs is subject to the following
                              limitations:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e277485" class="nobull">(A) If the patent
                                    involved was issued after the date of the enactment of this section, the
                                    period of extension determined on the basis of the regulatory review
                                    period determined under any such paragraph may not exceed five
                                    years.
                                 </li>
                                 <li id="d0e277489" class="nobull">(B) If the patent
                                    involved was issued before the date of the enactment of this section and
                                    —
                                    <ul style="list-style-type: none;">
                                       <li id="" class="nobull">
                                          <p id=""></p>
                                       </li>
                                       <li id="d0e277493" class="nobull">(i) no request for
                                          an exemption described in paragraph (1)(B) or (4)(B) was submitted
                                          and no request for the authority described in paragraph (5)(B) was
                                          submitted,
                                       </li>
                                       <li id="d0e277497" class="nobull">(ii) no major health
                                          or environment effects test described in paragraph (2)(B) or (4)(B)
                                          was initiated and no petition for a regulation or application for
                                          registration described in such paragraph was submitted,
                                          or
                                       </li>
                                       <li id="d0e277504" class="nobull">(iii) no clinical
                                          investigation described in paragraph (3) was begun or product
                                          development protocol described in such paragraph was submitted,
                                          before such date for the approved product the period of extension
                                          determined on the basis of the regulatory review period determined
                                          under any such paragraph may not exceed five years.
                                       </li>
                                    </ul>
                                 </li>
                                 <li id="d0e277509" class="nobull">(C) If the patent
                                    involved was issued before the date of the enactment of this section and
                                    if an action described in subparagraph (B) was taken before the date of
                                    enactment of this section with respect to the approved product and the
                                    commercial marketing or use of the product has not been approved before
                                    such date, the period of extension determined on the basis of the
                                    regulatory review period determined under such paragraph may not exceed
                                    two years or in the case of an approved product which is a new animal
                                    drug or veterinary biological product (as those terms are used in the
                                    Federal Food, Drug, and Cosmetic Act or the Virus-Serum-Toxin Act), three
                                    years.
                                 </li>
                              </ul>
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                     </div>
                     <p id="d0e277515">After reviewing the information
                        provided by the regulatory agency, if the Office determines the patent to be eligible for
                        extension, the Office then calculates the length of extension for which the patent is
                        eligible under the appropriate statutory provisions (<b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C. 156(c)</a></b>;
                        <b><a href="mpep-9020-appx-r.html#d0e332354">37
                              CFR 1.750</a></b>). The length of extension is subject to the limitations of
                        <b><a href="mpep-9015-appx-l.html#d0e304007">35 U.S.C.
                              156(c)(3)</a></b> and <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C. 156(g)(6)</a></b>. A Notice of Final
                        Determination is mailed to applicant which states the length of extension for which the
                        application has been determined to be eligible and the calculations used to determine the
                        length of extension. Recently mailed Notices of Final Determination are posted in the
                        Freedom of Information (FOIA) section of the USPTO Web site (www.uspto.gov) with other
                        Decisions of the Director. The notice provides a period, usually one month, in which the
                        applicant can request reconsideration of any aspect of the Office determination as to
                        eligibility or the length of extension for which the application has been found
                        eligible.
                     </p>
                     <p id="d0e277532">If the application has been determined
                        to be ineligible for patent term extension, an appropriate Notice of Final Determination is
                        mailed to applicant which dismisses the application and sets forth the basis for the
                        dismissal. The applicant is given a period, usually one month, in which to seek
                        reconsideration of the determination.
                     </p>
                     <p id="d0e277535">If the patent is found to be eligible
                        for extension, the Notice of Final Determination may include text similar to the
                        following:
                     </p>
                     <div id="">
                        <h2>
                           <p id="d0e277538"> A determination has been made that U.S. Patent No. ___,
                              which claims the human drug ___, is eligible for patent term extension under
                              <b><a href="mpep-9015-appx-l.html#d0e303884">35
                                    U.S.C. 156</a></b>. The period of extension has been determined to be
                              ___.
                           </p>
                           <p id="d0e277544"> A single request for reconsideration of this final
                              determination as to the length of extension of the term of the patent may be made if
                              filed within <span class="Underline">one month</span> of the date of this
                              notice. Extensions of time under <b><a href="mpep-9020-appx-r.html#d0e323655">37 CFR 1.136(a)</a></b> are not applicable
                              to this time period. In the absence of such request for reconsideration, the Director
                              will issue a certificate of extension, under seal, for a period of ___
                              days.
                           </p>
                           <p id="d0e277558"> The period of extension has been calculated using the FDA
                              determination of the length of the regulatory review period published in the Federal
                              Register of ___. Under <b><a href="mpep-9015-appx-l.html#d0e303995">35 U.S.C. 156(c)</a></b></p>
                           <p id="d0e277561"> Period of Extension = RRP - PGRRP - DD - ½ (TP -
                              PGTP)1
                           </p>
                           <p id=""><sup>1</sup>Consistent with <b><a href="mpep-9015-appx-l.html#d0e303995">35 U.S.C. 156(c)</a></b> ,
                              “RRP” is the total number of days in the regulatory review period, “PGRRP” is the number
                              of days of the RRP which were on and before the date on which the patent issued, “DD” is
                              the number of days of the RRP that the applicant did not act with due diligence, “TP” is
                              the testing phase period described in paragraphs (1)(B)(i), (2)(B)(i), (3)(B)(i),
                              (4)(B)(i), and (5)(B)(i) of subsection (g) of <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C. 156</a></b>, and “PGTP” is the
                              number of days of the TP which were on and before the date on which the patent issued,
                              wherein half days are ignored for purposes of the subtraction of ½ (TP -
                              PGTP).
                           </p>
                           <p id="d0e277570"> Since the regulatory review period began __, before the
                              patent issued ___, only that portion of the regulatory review period occurring after the
                              date the patent issued has been considered in the above determination of the length of
                              the extension period <b><a href="mpep-9015-appx-l.html#d0e303884">35&nbsp;U.S.C. 156(c)</a></b>. (From __ to ___
                              is___ days; this period is subtracted for the number of days occurring in the testing
                              phase according to the FDA determination of the length of the regulatory review period.)
                              No determination of a lack of due diligence under <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C. 156(c)(1</a></b>)
                              was made.
                           </p>
                           <p id="d0e277579"> The 14 year exception of <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C.
                                    156(c)(3)</a></b> operates to limit the term of the extension in the
                              present situation because it provides that the period remaining in the term of the
                              patent measured from the date of approval of the approved product (___) when added to
                              the period of extension calculated above (___ days) cannot exceed fourteen years. The
                              period of extension is thus limited to ___, by operation of <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C.
                                    156(c)(3)</a></b>. Since the patent term (<b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                                    154</a></b>) would expire on ___, the period of extension is the number of
                              days to extend the term of the patent from its expiration date to and including ___, or
                              ___ days.
                           </p>
                           <p id="d0e277591"> The limitations of <b><a href="mpep-9015-appx-l.html#d0e303884">35 U.S.C. 156(g)(6)</a></b>
                              do not operate to further reduce the period of extension determined
                              above.
                           </p>
                        </h2>
                     </div>
                     <p id="d0e277597">See <b><a href="s2759.html#d0e277764">MPEP §
                              2759</a></b> for further information pertaining to the issuance of a
                        certificate of extension. 
                     </p>
                     <p id="d0e277603">A patent term extension generally
                        extends the patent from its “original expiration date,” as defined by <b><a href="mpep-9015-appx-l.html#d0e303482">35 U.S.C.
                              154</a></b> to include extension under former 35&nbsp;U.S.C. 154(b) (for
                        applications filed between June 8, 1995 and May 28, 2000) and patent term adjustment under
                        <b><a href="mpep-9015-appx-l.html#d0e303525">35 U.S.C.
                              154(b)</a></b> (for applications filed on or after May 29,
                        2000).
                     </p>
                     <p id="d0e277621">No certificate or extension will be
                        issued if the term of a patent cannot be extended, even though the patent is otherwise
                        determined to be eligible for extension. In such situations the final determination would
                        issue indicating that no certificate will issue.
                     </p>
                     <div class="Section">
                        <h2 class="section1" id="d0e277624">I.
                           &nbsp;&nbsp;CALCULATION OF PATENT TERM EXTENSION
                        </h2>
                        <p id="d0e277628">The procedure for calculating the
                           length of the patent term extension is set forth for human drugs, antibiotic drugs, and
                           human biological products in <b><a href="mpep-9020-appx-r.html#d0e332453">37&nbsp;CFR 1.775</a></b>; for food or color
                           additives in <b><a href="mpep-9020-appx-r.html#d0e332572">37 CFR 1.776</a></b>; for medical devices in
                           <b><a href="mpep-9020-appx-r.html#d0e332687">37
                                 CFR 1.777</a></b>; for animal drug products in <b><a href="mpep-9020-appx-r.html#d0e332802">37 CFR 1.778</a></b>; and
                           for veterinary biological products in <b><a href="mpep-9020-appx-r.html#d0e332917">37 CFR 1.779</a></b>. The
                           length of patent term extension is the length of the regulatory review period as
                           determined by the Secretary of Health and Human Services or the Secretary of
                           Agriculture, but reduced, where appropriate, by the time periods provided in
                           <b><a href="mpep-9020-appx-r.html#d0e332453">37
                                 CFR 1.775</a></b> - <b><a href="mpep-9020-appx-r.html#d0e332917">1.779</a></b>. The Office will rely on the
                           Secretary’s determination of the length of the regulatory review period when calculating
                           the length of the extension period under <b><a href="mpep-9020-appx-r.html#d0e332453">37 CFR 1.775</a></b> -
                           <b><a href="mpep-9020-appx-r.html#d0e332917">1.779</a></b>.
                        </p>
                        <p id="d0e277655">Any part of the regulatory review
                           period which occurs before the patent was granted will not be counted toward patent term
                           extension. Any period in which the marketing applicant failed to exercise due diligence,
                           thereby unnecessarily adding to the length of the regulatory review period after the
                           patent issued, will not be considered in determining the length of the extension period.
                           In making the calculation of the extension period, half days will be ignored and thus
                           will not be subtracted from the regulatory review period.
                        </p>
                        <p id="d0e277658">For products other than animal drug
                           or veterinary biological products, the calculated extension period cannot exceed any of
                           the following statutory maximum periods of extension:
                        </p>
                        <div id="d0e277661" class="List">
                           <ul style="list-style-type: none;">
                              <li id="d0e277662" class="nobull">(A) If the period remaining in
                                 the term of the patent after the date of approval of the approved product when
                                 added to the calculated regulatory review period exceeds fourteen years, the
                                 period of extension shall be reduced so that the total of both such periods
                                 does not exceed <span class="Underline">fourteen</span>
                                 years;
                              </li>
                              <li id="d0e277669" class="nobull">(B) If the patent involved was
                                 issued <span class="Underline">after</span> September 24, 1984, (the
                                 date of enactment of the statute), the calculated period of extension may not
                                 exceed <span class="Underline">five</span> years;
                              </li>
                              <li id="d0e277679" class="nobull">(C) If the patent involved was
                                 issued <span class="Underline">before</span> September 24, 1984, (the
                                 date of enactment of the statute), and the regulatory review period proceeding
                                 started <span class="Underline">after</span> this date, the calculated
                                 period of extension may not exceed <span class="Underline">five
                                    years</span>; and 
                              </li>
                              <li id="d0e277692" class="nobull">(D) If the patent involved was
                                 issued <span class="Underline">before</span> September 24, 1984, (the
                                 date of enactment of the statute), and the regulatory review period proceeding
                                 started <span class="Underline">before</span> this date, and the
                                 commercial marketing or use of the product has been approved <span class="Underline">after</span> such date, the calculated period of
                                 extension may not exceed <span class="Underline">two</span>
                                 years.
                              </li>
                           </ul>
                        </div>
                        <p id="d0e277708">For animal drug or veterinary
                           biological products, the calculated extension period cannot exceed any of the following
                           statutory maximum periods of extension:
                        </p>
                        <div id="d0e277711" class="List">
                           <ul style="list-style-type: none;">
                              <li id="d0e277712" class="nobull">(A) If the period remaining in
                                 the term of the&nbsp;patent after the date of approval of the approved product when
                                 added to the calculated regulatory review period exceeds fourteen years, the
                                 period of extension shall be reduced so that the total of both such periods
                                 does not exceed <span class="Underline">fourteen</span>
                                 years;
                              </li>
                              <li id="d0e277719" class="nobull">(B) If the patent involved was
                                 issued <span class="Underline">after</span> November 16, 1988, the
                                 calculated period of extension may not exceed <span class="Underline">five</span> years;
                              </li>
                              <li id="d0e277729" class="nobull">(C) If the patent involved was
                                 issued <span class="Underline">before</span> November 16, 1988, and
                                 the regulatory review period proceeding started <span class="Underline">after</span> this date, the calculated period of extension may not
                                 exceed <span class="Underline">five</span> years; and
                              </li>
                              <li id="d0e277742" class="nobull">(D) If the patent involved was
                                 issued <span class="Underline">before</span> November 16, 1988, and
                                 the regulatory review period proceeding started <span class="Underline">before</span> this date, and the commercial marketing or use of the
                                 product has been approved <span class="Underline">after</span> such
                                 date, the calculated period of extension may not exceed <span class="Underline">three</span> years.
                              </li>
                           </ul>
                        </div>
                        <p id="d0e277758">The patent term extension of a
                           patent that issued before September 24, 1984, where the regulatory review period began
                           and ended before September 24, 1984, would only be a function of the regulatory review
                           period and the fourteen-year limit, and may be extended for more than five years.
                           <i>Hoechst Aktiengesellschaft v. Quigg,</i> 917 F2d 522,
                           525, 16 USPQ2d 1549, 1551 (Fed. Cir. 1990).
                        </p>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2701.html">2701-Patent Term</a></li>
               <li xmlns=""><a href="s2702-2709.html">2702-2709-[Reserved]</a></li>
               <li xmlns=""><a href="s2710.html">2710-Term Extensions or Adjustments for Delays Within the USPTO Under 35 U.S.C. 154</a></li>
               <li xmlns=""><a href="s2711-2719.html">2711-2719-[Reserved]</a></li>
               <li xmlns=""><a href="s2720.html">2720-Applications Filed Between June 8, 1995, and May 28, 2000</a></li>
               <li xmlns=""><a href="s2721-2729.html">2721-2729-[Reserved]</a></li>
               <li xmlns=""><a href="s2730.html">2730-Applications Filed on or After May 29, 2000; Grounds for Adjustment</a></li>
               <li xmlns=""><a href="s2731.html">2731-Period of Adjustment</a></li>
               <li xmlns=""><a href="s2732.html">2732-Reduction of Period of Adjustment of Patent Term</a></li>
               <li xmlns=""><a href="s2733.html">2733-Patent Term Adjustment Determination</a></li>
               <li xmlns=""><a href="s2734.html">2734-Application for Patent Term Adjustment; Due Care Showing</a></li>
               <li xmlns=""><a href="s2735.html">2735-[Reserved]</a></li>
               <li xmlns=""><a href="s2736.html">2736-Third Party Papers</a></li>
               <li xmlns=""><a href="s2737-2749.html">2737-2749-[Reserved]</a></li>
               <li xmlns=""><a href="s2750.html">2750-Patent Term Extension for Delays at other Agencies under 35 U.S.C. 156</a></li>
               <li xmlns=""><a href="s2751.html">2751-Eligibility Requirements</a></li>
               <li xmlns=""><a href="s2752.html">2752-Patent Term Extension Applicant</a></li>
               <li xmlns=""><a href="s2753.html">2753-Application Contents</a></li>
               <li xmlns=""><a href="s2754.html">2754-Filing Date</a><ul>
                     <li><a href="s2754.html#d0e276883">2754.01-Deadline for Filing an Application Under 35 U.S.C. 156(d)(1)</a></li>
                     <li><a href="s2754.html#d0e276901">2754.02-Filing Window for an Application Under 35 U.S.C. 156(d)(5)</a></li>
                     <li><a href="s2754.html#d0e276937">2754.03-Filing of a Request for an Extension Under 35 U.S.C. 156(e)(2)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2755.html">2755-Eligibility Determination</a><ul>
                     <li><a href="s2755.html#d0e276994">2755.01-Interim Extension of Patent Term During the Processing of the Application</a></li>
                     <li><a href="s2755.html#d0e277100">2755.02-Interim Extension of Patent Term Before Product Approval</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2756.html">2756-Correspondence Between the USPTO and the Regulatory Agency</a></li>
               <li xmlns=""><a href="s2757.html">2757-Regulatory Agency Determination of the Length of the Regulatory Review Period</a><ul>
                     <li><a href="s2757.html#d0e277434">2757.01-Due Diligence Determination</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2758.html">2758-Notice of Final Determination - Calculation of Patent Term Extension</a></li>
               <li xmlns=""><a href="s2759.html">2759-Certificate of Extension of Patent Term</a></li>
               <li xmlns=""><a href="s2760.html">2760-Trade Secret, Confidential, and Protective Order Material</a></li>
               <li xmlns=""><a href="s2761.html">2761-Multiple Applications for Extension of Term of the Same Patent or of Different Patents for the Same Regulatory Review Period
                     for a Product</a></li>
               <li xmlns=""><a href="s2762.html">2762-Duty of Disclosure in Patent Term Extension Proceedings</a></li>
               <li xmlns=""><a href="s2763.html">2763-Limitation of Third Party Participation</a></li>
               <li xmlns=""><a href="s2764.html">2764-Express Withdrawal of Application for Extension of Patent Term</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:35 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>